Ghislain Rocheleau

Search results

• Reports Summarize Liver Fibrosis Findings from Icahn School of Medicine at Mount Sinai (Comparison of Blood-based Liver Fibrosis Scores In the Mount Sinai Health System, Masld Registry, and Nhanes 2017-2020 Study)

  Nadkarni, G., Rocheleau, G., Do, R. & Bansal, M.

  25/09/24

  1 item of Media coverage

  Press/Media

• Findings from Icahn School of Medicine at Mount Sinai in the Area of Heart Disease Described (Exome Sequence Analysis Identifies Rare Coding Variants Associated With a Machine Learning-based Marker for Coronary Artery Disease)

  Park, J., Rocheleau, G. & Do, R.

  10/07/24

  1 item of Media coverage

  Press/Media

• AI tool finds rare variants linked to heart disease

  Do, R., Park, J. & Rocheleau, G.

  11/06/24

  2 items of Media coverage

  Press/Media

• Mount Sinai: New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes

  Park, J., Rocheleau, G. & Do, R.

  11/06/24

  1 item of Media coverage

  Press/Media

• New AI Tool Finds Rare Variants Linked to Heart Disease in 17 Genes

  Park, J., Rocheleau, G., Do, R. & Rosenson, R. S.

  11/06/24

  1 item of Media coverage

  Press/Media

• AI Tool Discovers 17 Genes With Rare Variants Tied to Heart Disease

  Park, J., Rocheleau, G. & Do, R.

  11/06/24

  1 item of Media coverage

  Press/Media

• New AI tool finds rare variants linked to heart disease in 17 genes

  Park, J., Rocheleau, G. & Do, R.

  11/06/24

  2 items of Media coverage

  Press/Media

• New AI tool finds rare variants linked to heart disease in 17 genes

  Park, J., Rocheleau, G. & Do, R.

  11/06/24

  3 items of Media coverage

  Press/Media

• Studies from Icahn School of Medicine at Mount Sinai Provide New Data on Clinical Trial Research (Development of a Human Genetics-guided Priority Score for 19,365 Genes and 399 Drug Indications)

  Park, J., Stein, D., Rocheleau, G., Do, R., Schlessinger, A. & Itan, Y.

  30/01/24

  1 item of Media coverage

  Press/Media

• Novel Genetic Priority Score Unveiled to Enhance Target Prioritization in Drug Development

  Park, J., Stein, D., Rocheleau, G., Do, R., Schlessinger, A. & Itan, Y.

  3/01/24

  76 items of Media coverage

  Press/Media

• Novel genetic priority score unveiled to enhance target prioritization in drug development

  Park, J., Stein, D., Rocheleau, G., Do, R., Schlessinger, A. & Itan, Y.

  3/01/24

  4 items of Media coverage

  Press/Media

• Mount Sinai Health System: Novel Genetic Priority Score Unveiled to Enhance Target Prioritization in Drug Development

  Park, J., Stein, D., Rocheleau, G., Do, R., Schlessinger, A. & Itan, Y.

  3/01/24

  1 item of Media coverage

  Press/Media

• Research from Icahn School of Medicine at Mount Sinai Provides New Study Findings on Autoimmunity (A machine learning model identifies patients in need of autoimmune disease testing using electronic health records)

  Nadkarni, G., Rocheleau, G., Do, R. & Park, J.

  16/05/23

  1 item of Media coverage

  Press/Media

• Recent Research from Icahn School of Medicine at Mount Sinai Highlight Findings in Heart Disease (Machine Learning-based Marker for Coronary Artery Disease: Derivation and Validation In Two Longitudinal Cohorts)

  Nadkarni, G., Rocheleau, G., Do, R. & Park, J.

  10/03/23

  1 item of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai Machine

  Rocheleau, G., Do, R. & Park, J.

  27/12/22

  1 item of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

  Rocheleau, G., Do, R. & Park, J.

  22/12/22

  1 item of Media coverage

  Press/Media

• Machine Learning-Derived Model could Lead to Better Disease Screening, Diagnostics, and Management

  Rocheleau, G., Do, R. & Park, J.

  21/12/22

  1 item of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

  Rocheleau, G., Do, R. & Park, J.

  20/12/22 → 21/12/22

  2 items of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai Machine; Could lead to better disease screening, diagnostics, and management

  Rocheleau, G., Do, R. & Park, J.

  21/12/22

  19 items of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai Machine; Could lead to better disease screening, diagnostics, and management.

  Rocheleau, G., Do, R. & Park, J.

  21/12/22

  1 item of Media coverage

  Press/Media

• Mount Sinai researchers construct a computer-derived marker for coronary artery disease

  Do, R., Rocheleau, G. & Park, J.

  21/12/22

  2 items of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

  Rocheleau, G., Do, R. & Park, J.

  20/12/22

  1 item of Media coverage

  Press/Media

• Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

  Rocheleau, G., Do, R. & Park, J.

  20/12/22

  1 item of Media coverage

  Press/Media

• Digital marker for coronary artery disease built by researchers at Mount Sinai

  Rocheleau, G., Do, R. & Park, J.

  19/12/22 → 20/12/22

  3 items of Media coverage

  Press/Media

• Most “Pathogenic” Genetic Variants Have a Low Risk of Actually Causing Disease

  Do, R., Rocheleau, G. & Loos, R.

  31/01/22

  1 item of Media coverage

  Press/Media